Identifying differential networks based on multi-platform gene expression data.
暂无分享,去创建一个
[1] Yingying Lu,et al. Inhibition of telomerase activity by HDV ribozyme in cancers , 2011, Journal of experimental & clinical cancer research : CR.
[2] W. Hahn,et al. Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian Cancer , 2013, Clinical Cancer Research.
[3] H. Zou,et al. Sparse precision matrix estimation via lasso penalized D-trace loss , 2014 .
[4] M. West,et al. Sparse graphical models for exploring gene expression data , 2004 .
[5] Caroline Dive,et al. Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer , 2010, Cancer biology & therapy.
[6] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[7] Muriel Médard,et al. Network deconvolution as a general method to distinguish direct dependencies in networks , 2013, Nature Biotechnology.
[8] Xing-Ming Zhao,et al. Inferring gene regulatory networks from gene expression data by path consistency algorithm based on conditional mutual information , 2012, Bioinform..
[9] Luonan Chen,et al. Part mutual information for quantifying direct associations in networks , 2016, Proceedings of the National Academy of Sciences.
[10] Bin Yu,et al. Estimation Stability With Cross-Validation (ESCV) , 2013, 1303.3128.
[11] Quaid Morris,et al. PLIDA: cross-platform gene expression normalization using perturbed topic models , 2014, Bioinform..
[12] N. Eckstein,et al. Platinum resistance in breast and ovarian cancer cell lines , 2011, Journal of experimental & clinical cancer research : CR.
[13] Xiaohua Hu,et al. Identifying binary protein-protein interactions from affinity purification mass spectrometry data , 2015, BMC Genomics.
[14] K. Aihara,et al. Personalized characterization of diseases using sample-specific networks , 2016, bioRxiv.
[15] J C Reed,et al. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. , 1995, Oncogene.
[16] M. Yuan,et al. Model selection and estimation in the Gaussian graphical model , 2007 .
[17] T. Okada,et al. Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells , 2013, Scientific Reports.
[18] Diogo M. Camacho,et al. Wisdom of crowds for robust gene network inference , 2012, Nature Methods.
[19] E. Levina,et al. Joint estimation of multiple graphical models. , 2011, Biometrika.
[20] Patrick Danaher,et al. The joint graphical lasso for inverse covariance estimation across multiple classes , 2011, Journal of the Royal Statistical Society. Series B, Statistical methodology.
[21] D. Berney,et al. The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers. , 2010, The American journal of pathology.
[22] Lin Yuan,et al. Gene differential coexpression analysis based on biweight correlation and maximum clique , 2014, BMC Bioinformatics.
[23] E. Schadt. Molecular networks as sensors and drivers of common human diseases , 2009, Nature.
[24] P. Zawierucha,et al. Microarray-based detection and expression analysis of extracellular matrix proteins in drug‑resistant ovarian cancer cell lines. , 2014, Oncology reports.
[25] Peng Yang,et al. Detecting temporal protein complexes from dynamic protein-protein interaction networks , 2014, BMC Bioinformatics.
[26] D. Soprano,et al. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. , 2007, Cancer research.
[27] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[28] W. Goessler,et al. Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation , 2006, BMC Cancer.
[29] A. Fuente,et al. From ‘differential expression’ to ‘differential networking’ – identification of dysfunctional regulatory networks in diseases , 2010 .
[30] Joshy George,et al. Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas , 2009, Clinical Cancer Research.
[31] B. Kholodenko,et al. The dynamic control of signal transduction networks in cancer cells , 2015, Nature Reviews Cancer.
[32] K. Strimmer,et al. Statistical Applications in Genetics and Molecular Biology A Shrinkage Approach to Large-Scale Covariance Matrix Estimation and Implications for Functional Genomics , 2011 .
[33] Adrian V. Lee,et al. Oncogenic Transformation by the Signaling Adaptor Proteins Insulin Receptor Substrate (IRS)-1 and IRS-2 , 2007, Cell cycle.
[34] Stephen P. Boyd,et al. Distributed Optimization and Statistical Learning via the Alternating Direction Method of Multipliers , 2011, Found. Trends Mach. Learn..
[35] M. Konopleva,et al. Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] Xiao-Fei Zhang,et al. Determining minimum set of driver nodes in protein-protein interaction networks , 2015, BMC Bioinformatics.
[37] Matthias Ernst,et al. Cancer research: past, present and future , 2011, Nature Reviews Cancer.
[38] Xingming Zhao,et al. Conditional mutual inclusive information enables accurate quantification of associations in gene regulatory networks , 2014, Nucleic acids research.
[39] Hui Yu,et al. Link-based quantitative methods to identify differentially coexpressed genes and gene Pairs , 2011, BMC Bioinformatics.
[40] V. Beral,et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.
[41] T. Cai,et al. Direct estimation of differential networks. , 2014, Biometrika.
[42] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[43] Kim-Anh Do,et al. DINGO: differential network analysis in genomics , 2015, Bioinform..
[44] Riet De Smet,et al. Advantages and limitations of current network inference methods , 2010, Nature Reviews Microbiology.
[45] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[46] H. Burris,et al. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway , 2013, Cancer Chemotherapy and Pharmacology.
[47] Frank Emmert-Streib,et al. Gene Sets Net Correlations Analysis (GSNCA): a multivariate differential coexpression test for gene sets , 2013, Bioinform..
[48] Trupti Joshi,et al. Inferring gene regulatory networks from multiple microarray datasets , 2006, Bioinform..
[49] Su-In Lee,et al. Node-based learning of multiple Gaussian graphical models , 2013, J. Mach. Learn. Res..
[50] Lawrence Steinman,et al. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.
[51] Ralf Zimmer,et al. Inferring gene regulatory networks by ANOVA , 2012, Bioinform..
[52] Chris Wiggins,et al. ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.
[53] W. Wilson,et al. Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. , 1997, Blood.